Skip to main content
Clinical Trials/NCT04703179
NCT04703179
Enrolling by Invitation
N/A

Rare and Undiagnosed Disease Research Biorepository

Mayo Clinic3 sites in 1 country5,000 target enrollmentNovember 20, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Undiagnosed Disease
Sponsor
Mayo Clinic
Enrollment
5000
Locations
3
Primary Endpoint
Enrollment of Study Participants
Status
Enrolling by Invitation
Last Updated
4 months ago

Overview

Brief Summary

This research study is being done to find markers and identify causes of rare and undiagnosed diseases by analyzing patient's DNA (i.e., genetic material), RNA, plasma, urine, tissues, or other samples that could be informative of symptoms. Researchers are creating a biobank (library) of samples and information to learn more about treating rare and undiagnosed diseases.

Registry
clinicaltrials.gov
Start Date
November 20, 2020
End Date
November 1, 2026
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Filippo Pinto e Vairo

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Has Mayo Clinic or other medical health system ID, or another unique identifier
  • Able to provide informed consent
  • Must meet one of the following:
  • Individual must have evidence of a rare disease or a suspected genetic disorder as determined by a provider or genetic counselor
  • Biological family member of an enrolled individual

Exclusion Criteria

  • Individuals who have situations that would limit compliance with the study requirements
  • Institutionalized (i.e. Federal Medical Prison)

Outcomes

Primary Outcomes

Enrollment of Study Participants

Time Frame: 5 years

5,000 participants to be accrued

Secondary Outcomes

  • Discovery of Disease Mechanisms and Therapeutic Approaches(5 years)
  • Body-of-Knowledge(5 years)
  • Diagnostic Yield(5 years)

Study Sites (3)

Loading locations...

Similar Trials